Clinical Techniques
Clinical Trials Summary Table
Unlock FRCOphth Part 1 Study Notes to access this content.
Get access| Phase | Subjects | Comments |
| 0 | Humans | Microdosing for safety |
| I | Healthy volunteers | Safety, side effects, pharmacokinetics and pharmacodynamics |
| II | Target patients | IIA: dosingIIB: efficacy |
| III | Larger group of target patients | Effectiveness vs gold standard (RCTs) |
| IV | Target group: marketed | Post-marketing surveillance of side effects (eg. yellow card system) |